Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Enzo Biochem Inc.
DescriptionAutologous colon-derived antigens
Molecular Target Not applicable
Mechanism of ActionImmune modulation
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationCrohn's disease
Indication DetailsTreat Crohn's disease (CD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today